Yucheng SUN, Xiaowei LIU, Honglei YU. LINC00525 targeting miR-338-3p promotes apoptosis and reduces paclitaxel resistance in gastric cancer cells[J]. Journal of Third Military Medical University, 2020, 42(22): 2202-2209.
DOI:
Yucheng SUN, Xiaowei LIU, Honglei YU. LINC00525 targeting miR-338-3p promotes apoptosis and reduces paclitaxel resistance in gastric cancer cells[J]. Journal of Third Military Medical University, 2020, 42(22): 2202-2209. DOI: 10.16016/j.1000-5404.202006247.
LINC00525 targeting miR-338-3p promotes apoptosis and reduces paclitaxel resistance in gastric cancer cells
To study the effect of modulating the expression of LINC00525 targeting miR-338-3p on apoptosis and drug resistance of gastric cancer cells.
Methods
2
Paclitaxel-resistant gastric cancer cells (HGC-27/PTX) were transfected with si-NC
si-LINC00525
miR-NC
miR-338-3p
si-LINC00525+anti-miR-NC
or si-LINC00525+anti-miR-338-3p. Cell counting kit 8 (CCK-8) was used to determine the cell survival rate after the treatments. Real-time fluorescence quantitative PCR (RT-qPCR) was performed to detect LINC00525 and miR-338-3p expression levels
and Western blotting was used to detect the protein expression in the cells. The changes in cell apoptosis and migration and invasion abilities were analyzed using annexin V-FITC/PI double staining and Transwell assays. Dual luciferase reporter assay was performed to verify the targeting relationship between LINC00525 and miR-338-3p.
Results
2
The expression of LINC00525 was increased and that of miR-338-3p was decreased in both in HGC-27 and HGC-27/PTX cells. Knocking down LINC00525 and overexpression of miR-338-3p significantly increased the expression of caspase-3
P21
and E-cadherin
lowered the expression of MMP-2
decreased the cell survival rate
increased the cell apoptotic rate
and suppressed cell migration and invasion. Dual luciferase reporter assay showed that LINC00525 was capable of regulating the targeted miR-338-3p
and inhibition of miR-338-3p obviously attenuated the effects of LINC00525 knockdown on the survival
migration
invasion
and apoptosis of HGC-27/PTX cells.
Conclusion
2
LINC00525 knockdown can inhibit the proliferation
migration and invasion
promote apoptosis and reduce paclitaxel resistance of HGC-27/PTX cells by up-regulating miR-338-3.
GUAN L L, ZHAO Q F, CHEN X B. Progress in multidrug resistance of gastric cancer[J]. Cancer Res Clin, 2017, 29(6): 422-425. DOI: 10.3760/cma.j.issn.1006-9801.2017.06.018.
HUANG S Q, WEI Z H.Research progress of long-chain non-coding RNA in the prognosis and drug resistance of gastric cancer[J]. Chin J Oncol Preu Treat, 2017, 9(5): 404-408. DOI: 10.3969/j.issn.1674-5671.2017.05.15.
ZHANG C, ZHANG L. Research progress in microRNA-associated mechanism, diagnosis and treatment of gastriccancer[J]. Me Recapitulate, 2019, 25(1): 55-59. DOI: 10.3969/j.issn.1006-2084.2019.01.011.
GUO P, CHENG P, WNAG P F, et al . Effect of LncRNA-MEG3 on proliferation and apoptosis of gastric cancer and chemosensitivity of cisplatin[J ] . Chin J Mod Med, 2019, 29(6): 16-21.
WANG X W, GUO Q Q, WEI Y, et al . Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non-small cell lung cancer[J ] . Oncol Rep, 2019, 42(6): 2402-2415. DOI: 10.3892/or.2019.7378.
WANG S S, LI J, YANG X P. Long non-coding RNA LINC00525 promotes the stemness and chemoresistance of colorectal cancer by targeting miR-507/ELK3 axis[J]. Int J Stem Cells, 2019, 12(2): 347-359. DOI: 10.15283/ijsc19041.
LIU S N, SUO J, WANG C X, et al .Downregulation of tissue miR-338-3p predicts unfavorable prognosis of gastric cancer[J ] . Cancer Biomark, 2017, 21(1): 117-122. DOI: 10.3233/cbm-170339.
SUN F, YU M C, YU J, et al . miR-338-3p functions as a tumor suppressor in gastric cancer by targeting PTP1B[J ] . Cell Death Dis, 2018, 9(5): 522. DOI: 10.1038/s41419-018-0611-0.
LIU X W, CAI H, SHENG W Q, et al . microRNAs expression profile related with response to preoperative radiochemotherapy in patients with locally advanced gastric cancer[J ] . BMC Cancer, 2018, 18(1): 1-8. DOI: 10.1186/s12885-018-4967-4.
HAN J, LI J, TANG K J, et al . miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin[J ] . Exp Cell Res, 2017, 360(2): 328-336. DOI: 10.1016/j.yexcr.2017.09.023.
ZHOU H Z, LI M W, XU H M. Recent progress in molecular mechanism of tumor drug resistance regulated by long non-coding RNA[J]. Pharm Biotechnol, 2018, 25(1): 75-80.
PENG P, ZHENG Q. Long non-coding RNA Linc00525 as a prognostic factor to regulate proliferation and apoptosis in colorectalcancer[J]. J Clin Oncol, 2019, 37(15_suppl): e15085. DOI: 10.1200/jco.2019.37.15_suppl.e15085.
GUO B, LIU L Y, YAO J Y, et al . miR-338-3p suppresses gastric cancer progression through a PTEN-AKT axis by targeting P-REX2a[J ] . Mol Cancer Res, 2014, 12(3): 313-321. DOI: 10.1158/1541-7786.MCR-13-0507.
XU H T, ZHAO L, FANG Q J, et al . MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α[J ] . PLoS ONE, 2014, 9(12): e115565. DOI: 10.1371/journal.pone.0115565.
NIU Q, LIU Z H, GAO J, et al . MiR-338-3p enhances ovarian cancer cell sensitivity tocisplatin by downregulating WNT2B[J ] . Yonsei Med J, 2019, 60(12): 1146-1156. DOI: 10.3349/ymj.2019.60.12.1146.